Eli Lilly

Eli Lilly Strengthens Obesity Portfolio with Promising Trial and Strategic Alliance

December 17, 2025

Eli Lilly Sets a New Benchmark in Weight-Loss Drug Development

Brett Shapiro - December 12, 2025

Eli Lilly Bets Billions on U.S. Expansion to Fuel Growth

kashif hafeez - December 11, 2025

Eli Lilly Strengthens Gene Therapy Ambitions with Strategic Acquisition

angelina - December 9, 2025

Eli Lilly’s Strategic Gains: Dividend Hike and China Market Access Bolster Long-Term Outlook

Brett Shapiro - December 9, 2025

Eli Lilly Gains Strategic Foothold in China with Key Reimbursement Win

Brett Shapiro - December 8, 2025

Eli Lilly Shares Face Market Correction Amid Strong Operational Performance

Brett Shapiro - December 6, 2025

Eli Lilly’s Bold Price Cut Sparks Investor Jitters

Brett Shapiro - December 1, 2025

Eli Lilly Reaches Unprecedented Market Valuation

angelina - November 27, 2025

Eli Lilly Shares Surge as Expansion and Analyst Confidence Fuel Rally

angelina - November 19, 2025

Eli Lilly Gains Strategic Foothold in India with Alzheimer’s Drug Approval

angelina - November 18, 2025

Eli Lilly Takes Bold Stand Against CVS in Pharmaceutical Power Struggle

November 12, 2025

Eli Lilly Stock: Major Expansion Initiatives Fuel Growth Outlook

kashif hafeez - November 11, 2025

Eli Lilly’s Strategic Surge: A Multi-Front Expansion in Obesity and Beyond

November 10, 2025

Eli Lilly’s Strategic Surge: Policy Shift and Pipeline Progress Fuel Growth

November 9, 2025

12 Page 1 of 2